2018
DOI: 10.1038/s41431-018-0303-3
|View full text |Cite
|
Sign up to set email alerts
|

Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants

Abstract: Holt-Oram syndrome (HOS) is an autosomal dominant condition characterised by the association of congenital heart defect (CHD), with or without rhythm disturbances and radial defects, due to TBX5 variants. The diagnosis is challenged by the variability of expression and the large phenotypic overlap with other conditions, like Okihiro syndrome, TAR syndrome or Fanconi disease. We retrospectively reviewed 212 patients referred for suspicion of HOS between 2002 and 2014, who underwent TBX5 screening. A TBX5 varian… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
51
0
11

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 44 publications
(63 citation statements)
references
References 51 publications
1
51
0
11
Order By: Relevance
“…It is one of the most common causes of heart failure and indications for transplant worldwide, therefore warrants prompt diagnosis and close surveillance within a multidisciplinary team (Norozi et al, 2006). The clinical diagnosis of HOS can be challenging, given the interand intrafamilial variability of cardiac and skeletal manifestations (Al-Qattan & Abou Al-Shaar, 2015;Basson et al, 1994;Brassington et al, 2003;Patel et al, 2012;Vanlerberghe et al, 2019). This is illustrated by the variable "route" to diagnosis exhibited within these families, with six of our participants being diagnosed with HOS in adulthood.…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations
“…It is one of the most common causes of heart failure and indications for transplant worldwide, therefore warrants prompt diagnosis and close surveillance within a multidisciplinary team (Norozi et al, 2006). The clinical diagnosis of HOS can be challenging, given the interand intrafamilial variability of cardiac and skeletal manifestations (Al-Qattan & Abou Al-Shaar, 2015;Basson et al, 1994;Brassington et al, 2003;Patel et al, 2012;Vanlerberghe et al, 2019). This is illustrated by the variable "route" to diagnosis exhibited within these families, with six of our participants being diagnosed with HOS in adulthood.…”
Section: Discussionmentioning
confidence: 98%
“…This was reconsidered after an episode of intraoperative tachycardia, and a molecular diagnosis of HOS was confirmed at age 34 years. (Ross et al, 2018) ; Basson et al, 1997;Boogerd et al, 2010;Brassington et al, 2003;Bruneau et al, 1999;Li et al, 1997 (Steimle & Moskowitz, 2017), whereas missense pathogenic variants are more likely to be associated with more complex cardiac phenotypes beyond septation (Steimle & Moskowitz, 2017;Vanlerberghe et al, 2019;Zhang et al, 2015b;Zhou et al, 2015;Zhu et al, 2017 -Shaar, 2015;Basson et al, 1999;Brassington et al, 2003;Ghosh et al, 2009;Li et al, 1997). This adds further evidence against the possibility of accurate prognostication based on genotype alone in families affected by TBX5-related disorders (Al-Qattan & Abou Al-Shaar, 2015;Brassington et al, 2003;Vanlerberghe et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The classification of loss-of-function variants in TBX5 relies on the identification of upper limb abnormalities consistent with Holt-Oram syndrome (HOS) 16 . Although there is minimal evidence, namely, in the form of case reports, identifying LVNC in the context of TBX5 variants is mechanistically plausible given the high prevalence of other structural abnormalities, including septal and valvular defects 22 . Additional studies are required to better understand whether the association of LVNC with TBX5 variants and HOS represents a true mechanistic link or an incidental finding.…”
Section: Discussionmentioning
confidence: 99%